One should carefully choose depletion markers and exclusion channel markers as mature PC subsets (and especially malignant PC) can express markers commonly associated with T cells (CD28), monocytes (CCR2), or NK cells (CD56). The gene discussed is CD28; the disease is pachyonychia congenita.